Feed TMO
TM

Thermo Fisher Scientific

TMO · NYSE

$675.36 -0.63% (-$4.25)
1M +13.17%
Market Cap $249.7B
P/E Ratio 35.79x
Div. Yield 0.27%
ROE 13.35%

Bulios Fair Price

$583.03

13.7% downside

Trenutna cena

$675.36

Podcenjeno Poštena vrednost Precenjeno

Po podatkih Bulios Fair Price je delnica TMO trenutno precenjena glede na svojo tržno ceno. Kako deluje?

Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?

Analiza

AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.

Piotroski F-Score Moderate
6/9
Valuation
19 /100
Expensive
P/E 35.79x
EV/EBITDA 26.36x
P/S 5.39x
Growth
24 /100
Declining
EPS growth 0.19%
Rev. growth 0.27%
FCF growth 3.07%
Profitability
83 /100
Strong
Gross margin 40.37%
Net margin 15.06%
Op. margin 17.69%
Quality
49 /100
Average
ROIC 7.45%
ROE 13.35%
ROA 6.17%
Debt
54 /100
Moderate
Debt/Equity 0.81x
Current ratio 1.55x
Int. coverage 5.88x
Stability
100 /100
Stable
Beta 0.85x
Rev. volatility 4.25%
EPS volatility 11.30%

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o TMO
Online

O podjetju

Thermo Fisher Scientific Inc. (TMO) is a global biotechnology company focusing on providing a wide range of laboratory technologies, scientific products, and services. The company is a leader in research and development, diagnostics, pharmaceuticals, and biotechnology. Thermo Fisher Scientific offers advanced products for the analysis of DNA, proteins, drugs, and other biological molecules, enabling accelerated scientific discovery and providing customers with tools to improve human health. With its global presence, strong research background, and innovative approach, the company has the potential for further growth and expanding its portfolio of scientific technologies. Investing in Thermo Fisher Scientific Inc. (TMO) shares can be an attractive choice for investors seeking a promising company with high research potential and impact on improving healthcare and scientific knowledge.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Medical - Diagnostics & Research

CEO

Marc N. Casper

Employees

125,000

Headquarters

Waltham

Prihajajoči dogodki

21 OKT.

Earnings

Upcoming earnings report

20d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.